Pressmeddelanden
Eevia Health receives a 927 KSEK (80 KEUR) sales order for a Lingonberry extract
Eevia Health Plc ("Eevia" or "The Company") has received an 80 KEUR sales order for Lingonberry extracts from a Finnish beauty brand.
CORRECTION: Eevia publishes the outcome of the rights issue
In the previous press release, 281,200 shares and 70,300 warrants that had been subscribed for in Finland with subscription rights had not been accounted for in the summary prese...
REG
CORRECTION: Eevia publishes the outcome of the rights issue
THE PRESS RELEASE WAS SENT OUT WITH THE MAR LABEL, WHICH IS INCORRECT. THEREFORE, WE RESEND WITHOUT THE MAR LABEL.THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS NOT INTENDED...
REG
MAR
Eevia publishes the outcome of the rights issue
THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS NOT INTENDED TO BE PUBLISHED, DISCLOSED, OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KO...
REG
Eevia has stopped the liquidity arrangement at Spotlight Stockmarket
Eevia Health Abp ("Eevia Health" or the "Company") has ended the arrangement with Mangold Fondkommission act as a liquidity provider for the company's shares at the Spotlight Sto...
Eevia Health secures an 868 KSEK sales order from a new customer for a new superior polyphenol extract
Eevia Health Plc ("Eevia" or "The Company") has won a 77 KEUR (868 KSEK) sales order from a new North American brand owner. The order is the first commercial customer for Feno-Ce...
Rapporter
Video
Finansiell kalender
Delårsrapport Q2 2024
Delårsrapport
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
Webbplats
eeviahealth.com/investors
Handelsinformation
Kurs ()
Förändring ()